Howard Alvin D 4
4 · Foamix Pharmaceuticals Ltd. · Filed Feb 28, 2018
Insider Transaction Report
Form 4
Howard Alvin D
VP Regulatory
Transactions
- Award
Ordinary Shares
2018-02-27+7,500→ 42,491 total - Award
Options
2018-02-27$6.35/sh+22,500$142,875→ 22,500 totalExercise: $6.35Exp: 2028-02-27→ Ordinary Shares (22,500 underlying)
Footnotes (4)
- [F1]This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
- [F2]The ordinary shares underlying this restricted share unit award vest over a period of four years (25% on February 27, 2019 and 6.25% every three months thereafter) ending February 27, 2022.
- [F3]Each option represents a contingent right to purchase one ordinary share of the issuer.
- [F4]The ordinary shares underlying these options vest over a period of four years (25% on February 27, 2019 and 6.25% every three months thereafter) ending February 27, 2022.